Pharmacokinetics and Safety of EST, a New Thiol Protease Inhibitor in Patients With Muscle Diseases.

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.16.749
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase a in Patients With Fabry Disease

Journal of Inherited Metabolic Disease
Genetics
2019English

A New Class of Serine and Cysteine Protease Inhibitor With Chemotherapeutic Potential.

1998English

Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986142, a Novel Reversible BTK Inhibitor, in Healthy Participants

European Journal of Clinical Pharmacology
MedicinePharmacology
2017English

Antipain, a New Protease Inhibitor Isolated From Agtinomycetes

Journal of Antibiotics
Drug DiscoveryPharmacology
1972English

Bioavailability and Pharmacokinetics of Oral Topotecan: A New Topoisomerase I Inhibitor

British Journal of Cancer
Cancer ResearchOncology
1996English

Effects of Thiol Protease Inhibitors on Cell Cycle and Proliferation of Vascular Smooth Muscle Cells in Culture

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1993English

Safety, Efficacy, and Pharmacokinetics of Intravenous C1 Esterase Inhibitor (Human) Prophylaxis in Children With Hereditary Angioedema (HAE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Safety of a Cyclooxygenase-2 Inhibitor in Patients With Aspirin-Sensitive Asthma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2002English

Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, Following Oral Administration of Single Doses to HIV-Infected Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy